Inmune Bio (INMB) Leases (2019 - 2025)
Inmune Bio (INMB) has disclosed Leases for 7 consecutive years, with $914000.0 as the latest value for Q4 2025.
- Quarterly Leases rose 197.72% to $914000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $914000.0 through Dec 2025, up 197.72% year-over-year, with the annual reading at $914000.0 for FY2025, 197.72% up from the prior year.
- Leases hit $914000.0 in Q4 2025 for Inmune Bio, down from $1.1 million in the prior quarter.
- In the past five years, Leases ranged from a high of $1.1 million in Q3 2025 to a low of $128000.0 in Q3 2021.
- Historically, Leases has averaged $467000.0 across 5 years, with a median of $429000.0 in 2023.
- Biggest YoY gain for Leases was 374.45% in 2022; the steepest drop was 30.17% in 2022.
- Year by year, Leases stood at $726000.0 in 2021, then crashed by 30.17% to $507000.0 in 2022, then decreased by 18.34% to $414000.0 in 2023, then decreased by 25.85% to $307000.0 in 2024, then surged by 197.72% to $914000.0 in 2025.
- Business Quant data shows Leases for INMB at $914000.0 in Q4 2025, $1.1 million in Q3 2025, and $374000.0 in Q2 2025.